Suchergebnisse - "Kernéis, Solen"

PubPharm (179)

1

Cardiac Adverse Events and Remdesivir in Hospitalized Patients with Coronavirus Disease 2019 (COVID-19) : A Post Hoc Safety Analysis of the Randomized DisCoVeRy Trial

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2024

von Terzić, V. | Miantezila Basilua, J. | Billard, N. | +123

2

Novel scores relevant to antimicrobial resistance and hospital-acquired infections developed with data from a multi-hospital consortium in the Parisian region of France

enthalten in: The Journal of hospital infection | 2024

von Amarsy, R. | Granger, B. | Fournier, S. | +77

3

Neutralizing Antibody Levels as a Correlate of Protection Against SARS-CoV-2 Infection : A Modeling Analysis

enthalten in: Clinical pharmacology and therapeutics | 2024

von Lingas, G. | Planas, D. | Péré, H. | +18

4

Neutralizing Antibody Levels as a Correlate of Protection Against SARS‐CoV‐2 Infection : A Modeling Analysis

enthalten in: Clinical Pharmacology & Therapeutics | 2024

von Lingas, G. | Planas, D. | Péré, H. | +18

5

Characteristics, management, and outcomes of patients with infectious encephalitis requiring intensive care : A prospective multicentre observational study

enthalten in: Journal of critical care | 2023

von Fillatre, P. | Mailles, A. | Stahl, J. | +102

6

Advances in antibacterial treatment of adults with high-risk febrile neutropenia

enthalten in: The Journal of antimicrobial chemotherapy | 2023

von Contejean, A. | Maillard, A. | Canouï, E. | +6

ErratumIn: J Antimicrob Chemother. 2023 Nov 6;78(11):2784. - PMID 37758509

7

Surgical site infection after pelvic bone and soft tissue sarcoma resection : Risk factors, microbiology, and impact of extended postoperative antibiotic prophylaxis

enthalten in: Journal of surgical oncology | 2023

von Bensaid, S. | Contejean, A. | Morand, P. | +8

8

Rationale and evidence for the use of new beta-lactam/beta-lactamase inhibitor combinations and cefiderocol in critically ill patients

enthalten in: Annals of intensive care | 2023

von Barbier, F. | Hraiech, S. | Kernéis, S. | +6

9

Rationale and evidence for the use of new beta-lactam/beta-lactamase inhibitor combinations and cefiderocol in critically ill patients

enthalten in: Annals of intensive care | 2023

von Barbier, F. | Hraiech, S. | Kernéis, S. | +5

10

Rationale and evidence for the use of new beta-lactam/beta-lactamase inhibitor combinations and cefiderocol in critically ill patients

enthalten in: Annals of intensive care | 2023

von Barbier, F. | Hraiech, S. | Kernéis, S. | +5

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[18]